BOC Sciences has extensive experience in deuterated drug discovery and development, and we have built an industry-leading
DCL™ platform designed to provide customers with a broad and unparalleled portfolio of innovative drugs.
At BOC Sciences, we provide reliable deuterium expertise and consultative support. By working together to promote quality-oriented customer services, we have built a reputation as a reliable technology platform.
Over the years, BOC Sciences has leveraged its expertise in deuterium labeling technology to provide and develop innovative, targeted services to laboratories, medical and academic research centers around the world.
BOC Sciences has been deeply engaged in the field of deuterium technology for many years, and is committed to using our unique deuterium chemical labeling (DCL) platform to develop innovative drugs for cardiovascular diseases, metabolic diseases, autoimmune diseases, etc.